199 related articles for article (PubMed ID: 18068866)
21. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
Bernaudin F; Pondarré C; Galambrun C; Thuret I
Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
[TBL] [Abstract][Full Text] [Related]
22. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
[TBL] [Abstract][Full Text] [Related]
23. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Iannone R; Casella JF; Fuchs EJ; Chen AR; Jones RJ; Woolfrey A; Amylon M; Sullivan KM; Storb RF; Walters MC
Biol Blood Marrow Transplant; 2003 Aug; 9(8):519-28. PubMed ID: 12931121
[TBL] [Abstract][Full Text] [Related]
24. Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord.
Miniero R; Rocha V; Saracco P; Locatelli F; Brichard B; Nagler A; Roberts I; Yaniv I; Beksac M; Bernaudin F; Gluckman E
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S78-9. PubMed ID: 9715898
[TBL] [Abstract][Full Text] [Related]
25. Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.
Rosanwo TO; Bauer DE
Mol Ther; 2021 Nov; 29(11):3163-3178. PubMed ID: 34628053
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
Sii-Felice K; Giorgi M; Leboulch P; Payen E
Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
28. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
[TBL] [Abstract][Full Text] [Related]
29. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
[TBL] [Abstract][Full Text] [Related]
30. [Erythrocyte transfusions in hemoglobinopathies: indications].
Galacteros F
Transfus Clin Biol; 1994; 1(1):15-7. PubMed ID: 8186847
[No Abstract] [Full Text] [Related]
31. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.
Angelucci E; Matthes-Martin S; Baronciani D; Bernaudin F; Bonanomi S; Cappellini MD; Dalle JH; Di Bartolomeo P; de Heredia CD; Dickerhoff R; Giardini C; Gluckman E; Hussein AA; Kamani N; Minkov M; Locatelli F; Rocha V; Sedlacek P; Smiers F; Thuret I; Yaniv I; Cavazzana M; Peters C;
Haematologica; 2014 May; 99(5):811-20. PubMed ID: 24790059
[TBL] [Abstract][Full Text] [Related]
32. Towards gene therapy of hemoglobinopathies.
Beuzard Y
Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
[No Abstract] [Full Text] [Related]
33. Genome-based therapeutic interventions for β-type hemoglobinopathies.
Karamperis K; Tsoumpeli MT; Kounelis F; Koromina M; Mitropoulou C; Moutinho C; Patrinos GP
Hum Genomics; 2021 Jun; 15(1):32. PubMed ID: 34090531
[TBL] [Abstract][Full Text] [Related]
34. A plethora of gene therapies for hemoglobinopathies.
Dunbar CE
Nat Med; 2021 Feb; 27(2):202-204. PubMed ID: 33526930
[No Abstract] [Full Text] [Related]
35. Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.
Goussetis E; Efstathiou E; Paisiou A; Avgerinou G; Zisaki K; Giamouris VJ; Peristeri I; Kitra V; Vessalas G; Gamaletsou MN; Sipsas NV; Graphakos S
Transpl Infect Dis; 2015 Apr; 17(2):201-7. PubMed ID: 25645592
[TBL] [Abstract][Full Text] [Related]
36. Gene Therapy for β-Hemoglobinopathies.
Cavazzana M; Antoniani C; Miccio A
Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
[TBL] [Abstract][Full Text] [Related]
37. Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies.
Shin SH; Park SS; Park S; Jeon YW; Yoon JH; Yahng SA; Cho BS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Eom KS
Eur J Haematol; 2020 Oct; 105(4):387-398. PubMed ID: 32470197
[TBL] [Abstract][Full Text] [Related]
38. Transfusing children with hemoglobinopathies.
Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
[TBL] [Abstract][Full Text] [Related]
39. Clinical hemoglobinopathies: iron, lungs and new blood.
Morris CR; Singer ST; Walters MC
Curr Opin Hematol; 2006 Nov; 13(6):407-18. PubMed ID: 17053452
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies.
Westgren M; Ringden O; Eik-Nes S; Ek S; Anvret M; Brubakk AM; Bui TH; Giambona A; Kiserud T; Kjaeldgaard A; Maggio A; Markling L; Seiger A; Orlandi F
Transplantation; 1996 Apr; 61(8):1176-9. PubMed ID: 8610414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
